US · FONR
FONAR Corporation
- Sector
- Healthcare · Medical - Devices
- Headquarters
- Melville, NY 11747
- Website
- fonar.com
Price · as of 2025-06-30
$18.93
Market cap 114.82M
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $102.38 | +440.83% |
| Intrinsic Value(DCF) | $6.24 | -67.04% |
| Graham-Dodd Method(GD) | $33.25 | +75.62% |
| Graham Formula(GF) | $12.49 | -34% |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | $1.81 | $797.12 | $0.00 | $2.73 | $7.29 |
| 2012 | $3.25 | $62.42 | $2.40 | $5.73 | $25.73 |
| 2013 | $5.29 | $31.30 | $66.40 | $9.20 | $45.34 |
| 2014 | $12.10 | $53.43 | $448.40 | $12.31 | $77.61 |
| 2015 | $9.84 | $37.71 | $192.69 | $16.38 | $18.59 |
| 2016 | $20.02 | $40.02 | $126.69 | $19.85 | $34.37 |
| 2017 | $28.20 | $50.74 | $22.47 | $26.22 | $42.73 |
| 2018 | $23.95 | $49.84 | $6.52 | $31.94 | $41.66 |
| 2019 | $23.26 | $54.35 | $6.30 | $29.19 | $35.15 |
| 2020 | $25.38 | $44.20 | $2.26 | $24.95 | $8.06 |
| 2021 | $17.02 | $45.60 | $1.99 | $28.01 | $19.94 |
| 2022 | $14.76 | $75.44 | $2.41 | $31.77 | $31.05 |
| 2023 | $15.98 | $59.13 | $0.38 | $30.17 | $12.82 |
| 2024 | $16.49 | $43.25 | $0.00 | $33.78 | $20.21 |
| 2025 | $15.60 | $102.38 | $0.00 | $33.24 | $12.49 |
AI valuation
Our deep-learning model estimates FONAR Corporation's (FONR) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $102.38
- Current price
- $18.93
- AI upside
- +440.83%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$6.24
-67.04% upside
Graham-Dodd
$33.25
+75.62% upside
Graham Formula
$12.49
-34% upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| FONR | FONAR Corporation | $18.93 | 114.82M | +441% | -67% | +76% | -34% | 9.23 | 0.57 | 0.94 | 4.97 | — | 0.60 | 81.67% | 11.12% | 7.99% | 6.30% | 5.87% | 4.95% | 0.23 | 452.88 | 8.45 | 8.14 | -1.07 | -1961.00% | 143.00% | -4388.00% | 7.56% | 0.66 | 4.86% | 0.00% | 0.00% | 4.62% | 6.98 | 10.88 | 0.78 | 2.37 |
| APYX | Apyx Medical Corporation | $3.27 | 134.17M | +662% | -86% | — | — | -1.69 | 2.80 | 0.83 | -2.79 | -7.60 | 2.80 | 61.04% | -39.18% | -48.78% | -115.17% | -88.10% | -32.70% | 2.73 | -3.19 | 5.26 | 4.40 | -0.42 | 2222.00% | -811.00% | 22461.00% | -47.15% | -1.68 | -87.74% | 0.00% | 0.00% | 0.00% | -2.49 | -2.50 | 0.97 | -0.58 |
| ARTV | Artiva Biotherapeutics, I… | $5.82 | 142.85M | +335% | -18% | — | +3,479% | -2.00 | 0.70 | 520.26 | 0.62 | -0.59 | 0.70 | 100.00% | -26805.58% | -23303.98% | -530.93% | 65.16% | -41.55% | 0.08 | — | 15.39 | 15.15 | 0.40 | 33697.00% | -9925.00% | 984.00% | -42.63% | -4.49 | 53.92% | 0.00% | 0.00% | 3.20% | 0.60 | 0.73 | -161.31 | 1.72 |
| EDAP | Edap Tms S.a. | $4.37 | 163.4M | +598% | -76% | — | — | -4.26 | 1.98 | 1.26 | -4.08 | — | 2.16 | 41.42% | -32.03% | -29.66% | -38.88% | -87.65% | -21.42% | 0.34 | -87.01 | 1.85 | 1.33 | 1.00 | -1053.00% | 611.00% | -679.00% | -21.85% | -0.36 | -75.49% | 0.00% | 0.00% | 0.00% | -3.17 | -3.68 | 1.01 | 0.14 |
| HYPR | Hyperfine, Inc. | $1.07 | 81.53M | +2,340% | -64% | — | — | -1.74 | 1.45 | 5.51 | -0.80 | — | 1.45 | 45.70% | -335.33% | -315.90% | -61.03% | -410.39% | -53.19% | 0.01 | — | 6.15 | 5.26 | 0.89 | -968.00% | 1684.00% | -813.00% | -55.17% | -4.44 | -371.71% | 0.00% | 0.00% | 0.00% | -0.78 | -0.86 | 2.61 | -3.97 |
| IFRX | InflaRx N.V. | $0.92 | 62.33M | +5,018% | -48% | — | — | -1.32 | 0.99 | 367.43 | -0.95 | — | 0.99 | -1900.76% | -31973.69% | -27784.96% | -56.18% | -78.66% | -46.95% | 0.01 | -2566.39 | 5.06 | 1.30 | 0.39 | 0.00% | 16279.00% | 2826.00% | -79.79% | -3.43 | -72.12% | 0.00% | 0.00% | 9.72% | -0.82 | -0.89 | 261.45 | -5.01 |
| LUNG | Pulmonx Corporation | $1.58 | 65.17M | +1,684% | +90% | — | — | -5.19 | 3.41 | 3.49 | -4.87 | — | 3.50 | 74.00% | -68.87% | -67.30% | -55.25% | -138.32% | -33.11% | 0.66 | -16.45 | 5.58 | 4.72 | 0.28 | -1000.00% | 2201.00% | -1414.00% | -11.27% | -1.29 | -79.07% | 0.00% | 0.00% | 0.00% | -4.29 | -7.50 | 2.95 | -1.57 |
| NSPR | InspireMD, Inc. | $1.78 | 75.42M | +1,242% | -35% | — | — | -3.72 | 3.30 | 16.99 | -2.61 | — | 3.30 | 21.49% | -478.00% | -456.63% | -84.68% | -1143.45% | -67.77% | 0.06 | — | 5.28 | 4.80 | 0.50 | -732.00% | 1296.00% | 3887.00% | -19.54% | -2.85 | -794.20% | 0.00% | 0.00% | 7.17% | -2.59 | -3.73 | 12.38 | -2.29 |
| QIPT | Quipt Home Medical Corp. | $3.63 | 161.41M | +679% | +41,027% | -84% | — | -9.83 | 0.75 | 0.31 | 5.02 | -17.48 | 183.07 | 70.09% | -1.56% | -3.13% | -8.67% | -2.44% | -3.34% | 0.85 | -0.79 | 1.46 | 0.64 | 2.52 | 5625.00% | 3883.00% | 108.00% | 24.09% | 0.50 | 11.61% | 0.00% | 0.00% | 0.12% | -39.68 | 8.33 | 0.62 | 0.40 |
| RCEL | AVITA Medical, Inc. | $5.03 | 124.96M | +486% | -58% | — | — | -3.02 | -8.82 | 2.05 | -3.30 | — | -6.59 | 82.13% | -58.56% | -67.85% | 799.72% | 463.33% | -71.40% | -0.13 | -8.38 | 0.57 | 0.44 | 0.20 | -2720.00% | 1145.00% | -4647.00% | -21.25% | -0.50 | 344.68% | 0.00% | 0.00% | 27.27% | -3.12 | -4.19 | 1.83 | -10.70 |
| VANI | Vivani Medical, Inc. | $1.23 | 72.67M | — | — | — | — | -2.53 | 3.37 | — | -2.49 | — | 3.37 | 0.00% | — | — | -122.42% | -125.35% | -53.77% | 1.10 | — | 3.41 | 3.11 | -0.04 | -1400.00% | — | -1319.00% | -35.94% | -3.47 | -108.41% | 0.00% | 0.00% | 0.00% | -2.45 | -2.83 | — | -4.16 |
About FONAR Corporation
FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates through two segments, Medical Equipment segment, and Physician Management and Diagnostic services segment. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. The company offers non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters and the development and implementation of practice growth and marketing strategies. The company owns and operates 5 diagnostic imaging facilities in Florida; and manages 39 MRI scanning facilities, including 25 facilities located in New York and 14 situated in Florida. It markets its scanners to private diagnostic imaging centers and hospitals. The company was incorporated in 1978 and is based in Melville, New York.
- CEO
- Timothy R. Damadian
- Employees
- 520
- Beta
- 0.99
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($6.24 ÷ $18.93) − 1 = -67.04% (DCF, example).